LB Pharmaceuticals Inc Common Stock LBRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$38.95M+25.4% | -$25.2M+60.1% | -$18.8M— | -$29.43M— | -$52.19M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $28.74M— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does LB Pharmaceuticals Inc Common Stock generate?
- LB Pharmaceuticals Inc Common Stock (LBRX) generated -$55.2M in operating cash flow over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's free cash flow?
- After $331.0K of capital expenditures, LB Pharmaceuticals Inc Common Stock's free cash flow was -$55.5M over the trailing twelve months.
- Where does LB Pharmaceuticals Inc Common Stock's cash flow data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.